Target intelligence / Profile preview

RRS1 antisense RNA 1 (RRS1-AS1)

Target
RRS1-AS1
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

RRS1 antisense RNA 1 (RRS1-AS1, also called RRS1 divergent transcript or RRS1-DT) is a long non-coding RNA (lncRNA) gene. It is expressed as an RNA molecule and does not encode a protein. RRS1-DT has been associated with atrial fibrillation in genetic studies, but its detailed molecular function and mechanism are not well-defined in the literature. It is classified as a regulatory RNA with putative roles in gene expression modulation, consistent with the general functions attributed to lncRNAs. No established roles as a drug target or biomarker are apparent, and there is no documentation of small-molecule or antibody drugs modulating this target. Notably, RRS1-DT should not be confused with the RRS1 protein (regulator of ribosome synthesis 1), which is an entirely different entity and essential for ribosome biogenesis—RRS1-AS1 is the antisense noncoding RNA transcript at the same genetic locus, potentially regulating RRS1 or neighboring genes, but it is not a receptor, enzyme, or classic therapeutic target.

Other names
RRS1-DTRRS1-AS1RRS1 antisense RNA 1 (head to head)RRS1 divergent transcript
02

Mechanism of action

Not applicable; RRS1-DT is not an established drug target.

03

Biological functions

The specific biological function of RRS1-AS1 is not comprehensively characterized, but it is a regulatory RNA molecule. By general lncRNA mechanisms, it may participate in transcriptional regulation, chromatin remodeling, or RNA processing.
04

Disease associations

Atrial fibrillation has been associated with RRS1-DT in some studies; broader roles in human disease are not well defined
05

Safety considerations

None reported, as this lncRNA is not a current therapeutic target.
06

Interacting drugs

None known; there is no established evidence of drugs directly targeting RRS1-DT
07

Biomarkers

None known specifically for RRS1-DT.

Beyond the preview

Go deeper on RRS1 antisense RNA 1 (RRS1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RRS1 antisense RNA 1 (RRS1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call